DAA2035 |
Alterations in frequency, developmental potential and gene expression profile in hematopoietic stem cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA2443 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
15.1% Decrease DNA Methylation |
|
DAA2444 |
AMP-activated protein kinase; non-catalytic gamma-3 subunit decreases with age |
Molecular |
mesenchymal stem cell |
Human |
PRKAG3 |
20.1% Decrease DNA Methylation |
|
DAA2442 |
ATP-binding cassette; sub-family A member 8 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
ABCA8 |
25.0% Decrease DNA Methylation |
|
DAA675 |
Beta-galactosidase expression increases in mesenchymal stem cells |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA2461 |
calcyphosine isoform b decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CAPS |
17.3% Decrease DNA Methylation |
|
DAA678 |
Capacity of mesenchymal stem cells to differentiate into osteoblasts may be decreased |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
DAA2450 |
casein kappa increases with age |
Molecular |
mesenchymal stem cell |
Human |
CSN3 |
16.3% Increase DNA Methylation |
|
DAA2455 |
CD34 antigen isoform b decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CD34 |
17.3% Decrease DNA Methylation |
|
DAA2454 |
chemokine (C-C motif) receptor 1 increases with age |
Molecular |
mesenchymal stem cell |
Human |
CCR1 |
31.2% Increase DNA Methylation |
|
DAA2441 |
complement factor D preproprotein increases with age |
Molecular |
mesenchymal stem cell |
Human |
CFD |
22.2% Increase DNA Methylation |
|
DAA2433 |
cyclin-dependent kinase inhibitor 2B isoform 2 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CDKN2B |
16.7% Decrease DNA Methylation |
|
DAA2437 |
dehydrogenase/reductase (SDR family) member 3 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
DHRS3 |
18.6% Decrease DNA Methylation |
|
DAA2027 |
DNA damage acummulates in hematopoietic stem and progenitor cells |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA1073 |
Fewer cells and higher apoptosis |
Physiological |
bone marrow |
Human |
— |
— |
|
DAA2460 |
gelsolin-like capping protein decreases with age |
Molecular |
mesenchymal stem cell |
Human |
CAPG |
19.3% Decrease DNA Methylation |
|
DAA1991 |
Hematopoietic cells accumulate random mutations |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
DAA2452 |
homeo box B1 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
HOXB1 |
49.3% Decrease DNA Methylation |
|
DAA2453 |
hypothetical protein LOC126353 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MISP |
24.8% Decrease DNA Methylation |
|
DAA2458 |
hypothetical protein LOC146433 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
IL34 |
27.7% Decrease DNA Methylation |
|
DAA2439 |
hypothetical protein LOC283598 increases with age |
Molecular |
mesenchymal stem cell |
Human |
C14orf177 |
42.5% Increase DNA Methylation |
|
DAA2463 |
Level of miR-19a decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MIR19A |
40.7% Decrease miRNA Level |
|
DAA2462 |
Level of miR-519d decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MIR519D |
44.7% Decrease miRNA Level |
|
DAA2445 |
L-pipecolic acid oxidase increases with age |
Molecular |
mesenchymal stem cell |
Human |
PIPOX |
32.2% Increase DNA Methylation |
|
DAA2449 |
microfibrillar associated protein 5 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
MFAP5 |
46.4% Decrease DNA Methylation |
|